Pacira BioSciences' Other Working Capital Changes fell 19393.52% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year increase of 6608.83%. This contributed to the annual value of $7.4 million for FY2024, which is 2364.35% down from last year.
Latest data reveals that Pacira BioSciences reported Other Working Capital Changes of -$4.7 million as of Q3 2025, which was down 19393.52% from $11.5 million recorded in Q2 2025.
Pacira BioSciences' 5-year Other Working Capital Changes high stood at $11.5 million for Q2 2025, and its period low was -$4.7 million during Q3 2025.
For the 5-year period, Pacira BioSciences' Other Working Capital Changes averaged around $1.7 million, with its median value being $2.1 million (2022).
Data for Pacira BioSciences' Other Working Capital Changes shows a peak YoY increase of 177716.54% (in 2022) and a maximum YoY decrease of 676250.0% (in 2022) over the last 5 years.
Pacira BioSciences' Other Working Capital Changes (Quarter) stood at -$3.8 million in 2021, then skyrocketed by 156.33% to $2.1 million in 2022, then rose by 24.5% to $2.7 million in 2023, then plummeted by 61.48% to $1.0 million in 2024, then tumbled by 562.23% to -$4.7 million in 2025.
Its Other Working Capital Changes stands at -$4.7 million for Q3 2025, versus $11.5 million for Q2 2025 and $7.1 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value